See more : Ilsung Pharmaceuticals Co., Ltd. (003120.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Public Joint Stock Company Polyus (PLZL.ME) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Public Joint Stock Company Polyus, a leading company in the Gold industry within the Basic Materials sector.
- Taiwan Shin Kong Security Co., Ltd. (9925.TW) Income Statement Analysis – Financial Results
- OJsys, Inc. (OJSY) Income Statement Analysis – Financial Results
- Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) Income Statement Analysis – Financial Results
- Aya Gold & Silver Inc. (AYASF) Income Statement Analysis – Financial Results
- Nagarro SE (DE000A3H2200.SG) Income Statement Analysis – Financial Results
Public Joint Stock Company Polyus (PLZL.ME)
About Public Joint Stock Company Polyus
Public Joint Stock Company Polyus, together with its subsidiaries, engages in the extraction, refining, and sale of gold. The company has primary operations in Krasnoyarsk, Irkutsk, Magadan, and Amur regions, as well as the Republic of Sakha in Russia. It also engages in the research and exploration works. The company was founded in 2005 and is based in Moscow, Russia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.44B | 4.26B | 4.97B | 5.00B | 4.01B | 2.92B | 2.72B | 2.46B | 2.19B | 2.24B | 2.26B |
| Cost of Revenue | 1.72B | 1.86B | 1.52B | 1.42B | 1.44B | 1.06B | 1.00B | 919.00M | 901.00M | 1.21B | 1.37B |
| Gross Profit | 3.72B | 2.40B | 3.45B | 3.58B | 2.57B | 1.85B | 1.72B | 1.54B | 1.29B | 1.03B | 890.11M |
| Gross Profit Ratio | 68.43% | 56.28% | 69.37% | 71.53% | 64.09% | 63.50% | 63.25% | 62.61% | 58.82% | 46.09% | 39.45% |
| Research & Development | 0.00 | 0.00 | 0.00 | 4.00M | 4.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 93.00M | 33.00M | 19.00M | 15.00M | 12.00M | 10.00M | 14.00M | 10.00M | 12.00M | 11.00M | 0.00 |
| Selling & Marketing | 21.00M | 51.00M | 40.00M | 43.00M | 54.00M | 49.00M | 36.00M | 19.00M | 16.00M | 16.00M | 0.00 |
| SG&A | 114.00M | 84.00M | 59.00M | 58.00M | 66.00M | 59.00M | 50.00M | 29.00M | 28.00M | 27.00M | 184.44M |
| Other Expenses | 434.00M | 316.00M | 275.00M | 278.00M | 284.00M | 214.00M | 216.00M | 149.00M | 95.00M | 169.00M | 493.91M |
| Operating Expenses | 548.00M | 400.00M | 334.00M | 336.00M | 350.00M | 273.00M | 266.00M | 178.00M | 123.00M | 196.00M | 678.34M |
| Cost & Expenses | 2.26B | 2.26B | 1.86B | 1.76B | 1.79B | 1.34B | 1.27B | 1.10B | 1.02B | 1.40B | 2.04B |
| Interest Income | 58.00M | 32.00M | 14.00M | 22.00M | 48.00M | 79.00M | 28.00M | 40.00M | 69.00M | 31.00M | 0.00 |
| Interest Expense | 371.00M | 236.00M | 206.00M | 243.00M | 312.00M | 282.00M | 225.00M | 187.00M | 95.00M | 40.00M | 0.00 |
| Depreciation & Amortization | 484.00M | 449.00M | 358.00M | 349.00M | 367.00M | 236.00M | 178.00M | 148.00M | 128.00M | 182.00M | 586.03M |
| EBITDA | 2.98B | 2.28B | 3.32B | 2.65B | 3.06B | 1.07B | 2.04B | 2.11B | 1.44B | 1.17B | 875.26M |
| EBITDA Ratio | 54.89% | 53.49% | 67.66% | 65.75% | 72.46% | 46.76% | 65.20% | 79.05% | 68.88% | 52.30% | 38.80% |
| Operating Income | 3.17B | 1.90B | 2.96B | 3.07B | 2.22B | 1.13B | 1.46B | 1.36B | 1.16B | 853.00M | 211.77M |
| Operating Income Ratio | 58.35% | 44.59% | 59.59% | 61.34% | 55.36% | 38.66% | 53.47% | 55.37% | 53.20% | 38.10% | 9.39% |
| Total Other Income/Expenses | -1.04B | 9.00M | -201.00M | -1.00B | 160.00M | -973.00M | 76.00M | 410.00M | 48.00M | -806.00M | 17.47M |
| Income Before Tax | 2.13B | 1.91B | 2.76B | 2.06B | 2.38B | 551.00M | 1.53B | 1.77B | 1.21B | 47.00M | 229.24M |
| Income Before Tax Ratio | 39.16% | 44.80% | 55.54% | 41.26% | 59.35% | 18.90% | 56.27% | 72.05% | 55.39% | 2.10% | 10.16% |
| Income Tax Expense | 400.00M | 348.00M | 480.00M | 416.00M | 433.00M | 77.00M | 290.00M | 326.00M | 191.00M | 222.00M | 94.56M |
| Net Income | 1.73B | 1.55B | 2.27B | 1.60B | 1.93B | 456.00M | 1.24B | 1.42B | 987.00M | -216.00M | 122.11M |
| Net Income Ratio | 31.81% | 36.36% | 45.71% | 31.97% | 48.21% | 15.64% | 45.57% | 57.77% | 45.11% | -9.65% | 5.41% |
| EPS | 14.80 | 11.56 | 16.82 | 11.89 | 14.52 | 3.45 | 9.64 | 10.09 | 5.18 | -1.16 | 0.66 |
| EPS Diluted | 14.80 | 11.56 | 16.77 | 11.85 | 14.48 | 3.38 | 9.61 | 10.09 | 5.18 | -1.16 | 0.66 |
| Weighted Avg Shares Out | 116.82M | 135.00M | 134.93M | 134.36M | 133.02M | 132.25M | 128.62M | 140.77M | 190.63M | 186.32M | 186.13M |
| Weighted Avg Shares Out (Dil) | 116.86M | 135.00M | 135.37M | 134.89M | 133.32M | 134.75M | 129.72M | 140.77M | 190.63M | 186.32M | 186.13M |
Source: https://incomestatements.info
Category: Stock Reports